Conditions for adapting workflows for secondary use (documentation and obtain consent); significance of group differences (n = 390). by Anja Köngeter (17959136)

“…<p>Conditions for adapting workflows for secondary use (documentation and obtain consent); significance of group differences (n = 390).…”

Concerns about providing patients’ clinical data for secondary use and significance of group differences (n = 382). by Anja Köngeter (17959136)

“…<p>Concerns about providing patients’ clinical data for secondary use and significance of group differences (n = 382).…”

Statistical significance of regression using power and time as factors affecting rupture. by William Chu Kwan (2251612)

Items showing significant score differences among different performance groups. by Ding-Ping Chen (164867)

Subjects:

Analysis of ERSP response for the PZ channel by comparing each condition in a pairwise manner. by Howe Yuan Zhu (17283139)

Subjects:

Significantly altered metabolic pathways and metabolites between CP and control groups. by Jiale Li (103362)

Subjects:

Statistical significance (p-value) for CKDMR regions comparison by age groups. by Arnauld Kaufman (12731976)

Subjects:

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

Subjects:

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Enrichment of the KEGG pathway using significantly changed metabolites from the combined LC‒MS analyses. by Caixia Zhang (467983)

Patterns, classification, and clinical significance of pharmacist interventions. by Osama Mohamed Ibrahim (12006954)

Subjects:

Boxplot analysis of significant biochemistry parameters in the AHDS and control groups. by Lukas Huber (3475895)

“…<p>This figure provides a boxplot analysis depicting significant variations in select plasma biochemistry markers between the AHDS and control groups. …”

Number of significant indices in post-hoc analysis using different adjustment methods. by Constantino A. García (20347872)

Subjects:

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Significant main effect of housing type. by Grace Hecker (18813445)

Subjects:

Significant interactions and main effects of day. by Grace Hecker (18813445)

Subjects:

Characteristics of population by income level. by Kenechukwu C. Ben-Umeh (17996326)

Subjects:

Prioritising public information leads to an overall decrease in cooperation occurring in networks. by Adam Lee Miles (14123916)

Clusters of significant altered cortical thickness between HIV-infected patients groups. by Rafael Ferracini Cabral (11824637)